Stay updated on Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial

Sign up to get notified when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays the study record for olaptesed pegol alone and with pembrolizumab in metastatic colorectal and pancreatic cancer, including its eligibility criteria, treatment plan, outcomes, and completed status.
    Difference
    49%
    Check dated 2026-11-09T12:31:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T11:45:49.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A sitewide notice announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T11:15:57.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T12:13:39.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The revision label in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:19:58.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study details, indicating access is blocked and a standard error screen is shown.
    Difference
    19%
    Check dated 2026-09-21T22:07:50.000Z thumbnail image

Stay in the know with updates to Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.